← All trials
NCT05714306
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2023
- Primary completion
- Mar 31, 2030
- Completion date
- Mar 31, 2030
- First posted
- Feb 6, 2023
- Last posted
- May 30, 2023
- Enrollment
- 16
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of LausanneLead sponsor
- University of LausanneOverall official - principal investigator
- University of LausanneReponsible party - principal investigator
- University of LausanneStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.